Susan G. Komen is making metastatic breast cancer (MBC) a top priority for public policy, research and ongoing education and patient support programs.
We must understand the biology of breast cancer and metastasis to develop drugs to slow, stop and prevent it. Metastatic breast cancers, by and large, are more resistant to the standard therapies we have today. That’s why it’s going to take innovative research and breakthrough discoveries to detect, target and find the cures for this disease. Susan G. Komen has invested more than $210 million in MBC research, supporting more than 500 research grants, including more than 50 clinical trials.
MBC is the most advanced stage of breast cancer—also known as Stage IV. It causes nearly all of the more than 42,000 breast cancer deaths each year in the United States. If you are a caregiver, a loved one, recently diagnosed with breast cancer, or living with MBC, we provide breast cancer information that is safe, accurate, reliable and based on scientific evidence and presented in a variety of formats.
In the United States, it’s estimated that more than 154,000 women and an unknown number of men have MBC. We want everyone to benefit from the scientific discoveries that are improving treatment for MBC and have the information and support needed to face the unique challenges and concerns of living with MBC. Komen works with partners in thousands of communities to unlock the scientific discoveries and deliver the support needed to help people with MBC.
We need policymakers to understand and prioritize the needs of women and men impacted by breast cancer, especially those living with metastatic breast cancer. Komen is actively engaged in Washington, D.C. and capitals across the country to create broad,
long-lasting changes that will expand research funding and increase access to high-quality, affordable care for all patient populations.
Clinical trials are key to making progress against MBC. Patients who join clinical trials receive high-quality care while
contributing to the research process that could help themselves or others.
Komen wants to help people with MBC find-and participate in-clinical trials.
Call our Clinical Trial Information Helpline to speak with a trained specialist.
or email at firstname.lastname@example.org.
Use the Metastic Trial Search Tool to find a Trial that’s Right for You.
Real perspective, stories and advice from those living with MBC.
What is Metastatic Breast Cancer? Pam Kohl explains
Living with Metastatic Breast Cancer with Jamil Rivers
The Importance of Forgiveness, by Abigail Letts
Komen offers conferences and events across the country to educate, empower and connect metastatic breast cancer patients with information, resources and others in the MBC community. Programs offer topical discussions specifically for people with MBC and their loved ones.
Second Annual Komen Louisiana MBC Virtual Conference
Live stream available to registrants
Baton Rouge, LA | Saturday, June 13, 2020
3rd Annual Metastatic Breast Cancer Conference
Independence, OH | Saturday, June 27, 2020
Metastatic Breast Cancer Conference
West Freehold, NJ | Sunday, August 09, 2020
3rd Annual Metastatic Breast Cancer Conference and Resource Fair
Chicago, IL | Friday, August 21, 2020
Greater Atlanta Metastatic Breast Cancer Conference
Atlanta, GA | Saturday, August 22, 2020
5th Northwest Metastatic Breast Cancer Conference
Puget Sound, WA | Saturday, September 12, 2020
Boise Metastatic Breast Cancer Conference
Boise, ID | Saturday, September 26, 2020
New York Metastatic Breast Cancer Conference
New York City, NY | Saturday, October 03, 2020
Live and Learn Conference
Carmel, IN | Saturday, October 03, 2020
San Francisco, CA | Saturday, October 10, 2020
Johnson City, TN | Tuesday, October 13, 2020
Midwest Metastatic Breast Cancer Conference
Bloomington, MN | Saturday, October 24, 2020
Westchester Metastatic Breast Cancer Conference
Westchester, NY | Saturday, November 07, 2020
Knoxville, TN | Friday, November 13, 2020
Charlotte Metastatic Breast Cancer Conference
Charlotte, NC | Wednesday, November 18, 2020